Skip to main content

IO Biotech, Inc.

IOBTDelisted Jun 8, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001865494

IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.

Q4 2024 vs. Q3 2024

How the institutions holding IO Biotech, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of IOBT: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders2027+7
Shares23.6M19.7M−3.90M (−16.5%)
Value$24.8M$18.2M−$6.66M (−26.8%)

New holders (12)

Institutions that held IO Biotech, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IOBT in Q4 2024
InstitutionSharesValue% of portfolio
Dauntless Investment Group, LLC747,646$687.8K2.91%
Landscape Capital Management, L.L.C.442,196$406.8K0.04%
Citadel Advisors LLC270,504$248.9K0.00%
Sectoral Asset Management Inc75,000$69.0K0.05%
Royal Bank of Canada60,000$55.0K0.00%
Vontobel Holding Ltd.32,667$30.1K0.00%
XTX Topco Ltd28,040$25.8K0.00%
Wealth Enhancement Advisory Services, LLC20,000$18.4K0.00%
PKS Advisory Services, LLC16,000$14.7K0.00%
Two Sigma Securities, LLC12,384$11.4K0.00%
SBI Securities Co., Ltd.130$1200.00%
Citigroup Inc5$50.00%

Sold out (5)

Institutions that held IO Biotech, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of IOBT in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Samsara BioCapital, LLC3,640,015$3.82M
Logos Global Management LP493,827$518.5K
Two Sigma Investments, LP30,000$31.5K
Virtu Financial LLC17,954$19.0K
Advisor Group Holdings, Inc.230$242